Akoya Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	12.56	83.13	74.23	113.08	17.01	11.64
Short-Term Investments	23.34	-	6.99	-	-	10.02
Cash & Short-Term Investments	35.9	83.13	81.22	113.08	17.01	21.66
Cash Growth	-54.33%	2.35%	-28.18%	564.94%	-21.48%	-
Accounts Receivable	12.79	16.99	9.73	9.44	6.47	13.17
Other Receivables	-	-	-	5.09	-	-
Receivables	12.79	16.99	9.73	14.54	6.47	13.17
Inventory	25.21	17.88	14.49	9.01	4.26	4.09
Prepaid Expenses	2.97	3.79	6.76	4.18	0.96	1.96
Total Current Assets	76.86	121.79	112.2	140.81	28.7	40.87
Property, Plant & Equipment	13.97	20.66	22.45	7.49	5.53	4.98
Goodwill	18.26	18.26	18.26	18.26	18.26	18.26
Other Intangible Assets	15.27	17.41	20.05	21.15	22.71	24.14
Long-Term Deferred Tax Assets	-	0.04	0.04	-	-	-
Long-Term Deferred Charges	-	0.33	0.33	-	0.27	-
Other Long-Term Assets	2.21	1.88	2.71	3.19	2.19	1.16
Total Assets	129.97	180.37	176.03	190.91	77.66	89.41
Accounts Payable	8.76	11.78	10.63	9.44	5.07	8.12
Accrued Expenses	6.77	10.43	11.16	12.28	5.43	6.04
Current Portion of Long-Term Debt	-	-	-	-	1.03	-
Current Portion of Leases	3.68	3.45	3.63	0.27	0.2	0.08
Current Unearned Revenue	6.19	6.69	6.28	4.48	3.84	4.38
Other Current Liabilities	2.6	3.01	5.36	1.21	1.59	2.54
Total Current Liabilities	27.99	35.35	37.06	27.68	17.16	21.16
Long-Term Debt	75.9	75.25	63.28	32.47	33.49	24.47
Long-Term Leases	5.34	7	8.88	0.2	0.28	0.21
Long-Term Unearned Revenue	3.09	3.19	2.11	1.33	1.01	0.91
Long-Term Deferred Tax Liabilities	0.11	0.04	0.09	0.03	0.17	0.16
Other Long-Term Liabilities	3.9	5.77	6.04	7.85	7.47	8.33
Total Liabilities	116.34	126.6	117.45	69.56	59.58	55.23
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	290.86	283.84	225.33	217.46	-	-
Retained Earnings	-277.24	-230.07	-166.75	-96.11	-52.28	-31.41
Comprehensive Income & Other	0.01	-	-0.01	-	-	-
Total Common Equity	13.63	53.77	58.58	121.35	-52.28	-31.41
Shareholders' Equity	13.63	53.77	58.58	121.35	18.08	34.19
Total Liabilities & Equity	129.97	180.37	176.03	190.91	77.66	89.41
Total Debt	84.92	85.71	75.78	32.94	34.99	24.75
Net Cash (Debt)	-45.62	-2.58	5.43	80.14	-17.99	-3.09
Net Cash Growth	-	-	-93.22%	-	-	-
Net Cash Per Share	-0.92	-0.06	0.14	2.98	-7.59	-1.36
Filing Date Shares Outstanding	49.56	49.14	38.34	37.48	2.56	2.29
Total Common Shares Outstanding	49.52	49.12	38.29	37.42	2.56	2.29
Working Capital	48.87	86.45	75.14	113.13	11.53	19.72
Book Value Per Share	0.28	1.09	1.53	3.24	-20.39	-13.74
Tangible Book Value	-19.9	18.1	20.27	81.94	-93.26	-73.81
Tangible Book Value Per Share	-0.40	0.37	0.53	2.19	-36.37	-32.28
Machinery	12.95	14.52	12.52	9.98	6.53	4.77
Leasehold Improvements	5.19	5.88	3.98	1.57	1.26	1.08

Source: S&P Capital IQ. Standard template. Financial Sources.